Close Icon

Carlyle and Healthcare Venture Funds Invest in Saama.

As part of a growth investment of up to $430M, Carlyle and venture funds from Merck, Pfizer, Amgen, McKesson and others have embraced AI technologies for accelerating the delivery of safe and effective medical treatments.

Do More with Data-Driven Drug Development.

State-of-the-art clintech from Saama is designed to streamline your workflows, automate time-consuming processes, and improve collaboration across clinical operations, medical review, data management, biostatistics, and pharmacovigilance.

Sponsors and CROs rely on Saama for data aggregation and artificial intelligence solutions that lead to better decision-making, eliminate delays, and significantly shrink drug development costs and timelines.

>

Saama's Intelligent Clinical Cloud Offering: Life Science Analytics Cloud (LSAC)

Accelerated Clinical Trials Icon

Accelerated
Clinical Trials

When all your clinical data is in one place and updated in real time, life’s much easier for your ClinOps and Medical Review teams.

Automated Data Management Icon

Automated
Data Quality

Data Managers have been underappreciated for too long. Eliminate manual work so they can pay attention to the data points that matter most.

Streamline Regulatory Submissions Icon

Streamline Regulatory Submissions

Pharmacovigilance teams can generate regulatory submissions in minutes, and actively monitor drug safety signals after drugs get approved.

Partners in Innovation: Saama Success Stories

0%

72% of Saama users say that Saama is a valuable technology partner.*

Saama builds long-lasting relationships with the most respected pharmaceutical companies, nonprofit organizations, universities, and government agencies in the world, by delivering game-changing solutions that improve clinical trial outcomes.

0%

Saama Reduces Manual Work

67% of Saama users say they purchased our technology to automate processes.*

Access Out-of-the-Box Features in 4 Weeks—Guaranteed.

Saama can put you on the fast track to clinical trial process innovation.